Rgenix
Get Full AccessDescription
- Rgenix is developing first-in-class drugs that target key pathways in cancer progression. Using a discovery platform developed by Rgenix's founding scientists at Rockefeller University, we have discovered several novel cancer targets that drive tumor growth and cancer progression. These targets regulate key components of the tumor micro-environment including immune cells and cancer metabolism pathways.Our discovery platform - which can be applied to virtually any tumor type - has yielded novel therapeutic targets for several high-unmet need cancer types to date. We aim to develop effective therapies against these targets that will provide durable and meaningful responses for cancer patients that lack effective therapies.Our lead therapy RGX-104 is a small molecule immunotherapy that blocks the ability of tumors to evade the immune system. RGX-104 has obtained FDA Orphan Drug Designation in several solid tumor types of high-unmet need and entered clinical trials in Q4 2016.
-
Headquarters:310 East 67th Street Suite 1-12, New York, New York, United States
More -
Phone Number: +1 646-590-9108
-
Website: https://www.rgenix.com
-
Employees:19
-
Revenue:$10 - 50M
-
Legal Name:Rgenix
-
Rgenix's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Rgenix
-
Where are Rgenix's Headquarters?
Rgenix's Headquarters are in 310 East 67th Street Suite 1-12,New York,New York,United States
-
What is Rgenix's phone number?
Rgenix's phone number is +1 646-590-9108
-
What is Rgenix's official website?
Rgenix's official website is https://www.rgenix.com
-
What is Rgenix's Revenue?
Rgenix's revenue is $10 - 50M
-
What is Rgenix's NAICS code?
Rgenix's NAICS code is 541713
-
How many employees are working in Rgenix
Rgenix has 19 employees
-
What is Rgenix's Industry?
Rgenix is in the industry of Biotechnology
-
Who is Rgenix's Vice President- Research And Development?
Rgenix's Vice President- Research And Development is Isabel Kurth

